An observational study in Biliary Atresia, Infant and Nutrition Support, sponsored by Children's Hospital of Fudan University. Recruiting at 1 site in China. Open to participants aged Up to 3 Months. Per ClinicalTrials.gov, last updated 2026-04-03.
Sponsored by Children's Hospital of Fudan University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Biliary Atresia with a site in China — 7 open to participants now, 9 under way, 1 of them phase 3. Biliary Atresia · China.
Among the 21 studies in Biliary Atresia with a site in China, this one is the 4th largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2021, is one of 10 observational ones, and was the 8th registered.
78 studies on the registry are indexed under Biliary Atresia; 26 are open to participants now.
Browse Biliary Atresia studies →7 of the 21 studies in Biliary Atresia with a site in China are open now. Recruiting first, the newest first:
Tongji Hospital · Sites in China
Ages 1 days–3 mo
Children's Hospital of Fudan University · Sites in China
Children's Hospital of Fudan University · Sites in China
Ages 14 days–90 days
Weibing Tang · Sites in China
Ages 6 mo–6 yrs
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Sites in China
Ages 1 days–3 mo · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 21 Biliary Atresia studies recruiting now, 3 (14%) set no upper age limit and 18 (86%) stop at 75 or younger; 21 take children under 18; 6 take healthy volunteers.
This study: Up to 3 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 3 · Phase 4 2
First in 2014; this study’s year is marked. 4 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 120 across 33 observational studies indexed under Biliary Atresia.
Median enrollment 160 across the 11 interventional studies, 200 across the 10 observational. Of the 6 that completed or were terminated, 2 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 21 have an industry lead sponsor. The 10 most frequent:
Children's Hospital of Fudan University is the lead sponsor of 268 studies on the registry; 94 are open to participants now.
Children's Hospital of Fudan University has 5 studies filed under Biliary Atresia — fewer than ten, so there is no comparison to draw.
1 of the studies in Biliary Atresia with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07940543Nanjing Children's HospitalConstruction of a Liver Metabolic Atlas in Biliary Atresia Based on Raman Spectroscopic Imaging | 2027-03-10 |
Add it to your calendar (.ics) → With an account.
Among the 21 studies in Biliary Atresia with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a prospective, single center and observational open clinical study.
Biliary atresia (BA) is a significant disease leading to liver failure in infancy, with BA accounting for 50% of infant liver transplantation cases. Many BA children experience complications related to malnutrition, particularly during the first year of life. These complications are primarily characterized by reduced muscle mass and structural protein, impaired bone mineralization, diminished fat reserves, and deficiencies in vitamins and trace elements. Some studies have indicated that oral administration of specialized medium-chain triglycerides (MCT) and branched-chain amino acids FSMP with polysaccharides still result in malnutrition and growth retardation among BA children, necessitating enteral nutrition support treatment through tube feeding. The American Association for the Study of Biliary Atresia conducted a study on the prognosis of 104 children with biliary atresia after Kasai surgery across six clinical centers. They found that the key period for changes in growth rate occurred six months post-surgery, with faster-growing children exhibiting better prognoses compared to those with slower growth rates. Active nutritional therapy can enhance the prognosis of children with biliary atresia, particularly before and after Kasai surgery within the initial six-month period following surgery. Currently, there is no standardized process for using Foods for Special Medical Purpose in China nor any regulations governing the addition and monitoring of trace elements and vitamins. Therefore, this study aims to improve overall outcomes for children with biliary atresia through standardized nutrition assessment procedures as well as education, intervention, and follow-up measures.A total of 300 hospitalized patients were enrolled, all of whom received high MCT formula nutritional support following the Kasai operation, in order to investigate the impact of high MCT formula on the nutritional status and growth of children with biliary atresia after undergoing the Kasai procedure.
The Kasai procedure for infants with biliary atresia under the age of 3 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The Kasai procedure for infants with biliary atresia under the age of 3 months.
Exclusion Criteria:
Infants aged 0-3 months who underwent Kasai operation for congenital biliary atresia and were able to receive enteral nutrition through oral or tube feeding were administered a high MCT formula powder + breast milk (with the high MCT formula powder accounting for ≥50%) after the Kasai operation. If breast milk was insufficient, regular formula was used as a substitute. The recommended energy intake was set at 100-130% of DRIs.
Z-scores of body weight
The patient will be weighed in the recumbent position on an electronic infant scale. Z-scores for weight for age (WAZ) were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 3 months after Kasai portoenterostomy
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 month after Kasai portoenterostomy
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 3 months after Kasai portoenterostomy
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 6 months after Kasai portoenterostomy
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 year after Kasai portoenterostomy
Z-scores of body weight
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 month after Kasai portoenterostomy
Z-scores of body weight
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 6 months after Kasai portoenterostomy
Z-scores of body weight
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 year after Kasai portoenterostomy
Z-scores of head circumference
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 month after Kasai portoenterostomy
Z-scores of head circumference
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 3 months after Kasai portoenterostomy
Z-scores of head circumference
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 6 months after Kasai portoenterostomy
Z-scores of head circumference
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame: 1 year after Kasai portoenterostomy
level of vitamin A
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
level of vitamin A
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
level of vitamin A
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
level of vitamin A
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
level of 25(OH) D
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
level of 25(OH) D
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
level of 25(OH) D
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
level of 25(OH) D
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
level of vitamin E
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
level of vitamin E
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
level of vitamin E
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
level of vitamin E
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
level of vitamin K
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
level of vitamin K
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
level of vitamin K
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
level of vitamin K
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Aspartate aminotransferase
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Aspartate aminotransferase
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Aspartate aminotransferase
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Aspartate aminotransferase
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Alanine aminotransferase
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Alanine aminotransferase
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Alanine aminotransferase
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Alanine aminotransferase
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Total Bilirubin
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Total Bilirubin
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Total Bilirubin
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Total Bilirubin
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Direct Bilirubin
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Direct Bilirubin
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Direct Bilirubin
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Direct Bilirubin
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Gamma-glutamyl transferase
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Gamma-glutamyl transferase
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Gamma-glutamyl transferase
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Gamma-glutamyl transferase
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Total bile acid
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Total bile acid
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Total bile acid
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Total bile acid
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
White blood cell
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
White blood cell
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
White blood cell
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
White blood cell
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
lymphocyte
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
lymphocyte
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
lymphocyte
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
lymphocyte
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Neutrophil count
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
Neutrophil count
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
Neutrophil count
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
Neutrophil count
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
International Normalized Ratio
Blood biochemical data are from clinical database.
Time frame: 1 month after Kasai portoenterostomy
International Normalized Ratio
Blood biochemical data are from clinical database.
Time frame: 3 months after Kasai portoenterostomy
International Normalized Ratio
Blood biochemical data are from clinical database.
Time frame: 6 months after Kasai portoenterostomy
International Normalized Ratio
Blood biochemical data are from clinical database.
Time frame: 1 year after Kasai portoenterostomy
Incidence of postoperative cholangitis
Data from clinical database
Time frame: 1 year after Kasai portoenterostomy
Liver transplantation
Data from clinical database
Time frame: 1 year after Kasai portoenterostomy
MMP-7
Data from clinical database
Time frame: 1 months after Kasai portoenterostomy
MMP-7
Data from clinical database
Time frame: 3 months after Kasai portoenterostomy
MMP-7
Data from clinical database
Time frame: 6 months after Kasai portoenterostomy
MMP-7
Data from clinical database
Time frame: 1 year after Kasai portoenterostomy
Intestinal flora
Data from clinical database
Time frame: 1 months after Kasai portoenterostomy
Intestinal flora
Data from clinical database
Time frame: 3 months after Kasai portoenterostomy
Intestinal flora
Data from clinical database
Time frame: 6 months after Kasai portoenterostomy
Intestinal flora
Data from clinical database
Time frame: 1 year after Kasai portoenterostomy
bile acid spectrum
Data from clinical database
Time frame: 1 months after Kasai portoenterostomy
bile acid spectrum
Data from clinical database
Time frame: 3 months after Kasai portoenterostomy
bile acid spectrum
Data from clinical database
Time frame: 6 months after Kasai portoenterostomy
bile acid spectrum
Data from clinical database
Time frame: 1 year after Kasai portoenterostomy
Started Oct 2021 (actual). Primary completion is estimated for Dec 2028, 86 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Fudan University →